MaaT Pharma and Skyepharma's new cGMP manufacturing facility in Lyon, France. (Credit: MaaT Pharma)
September 13, 2023 10:40 AM EDTUpdated 11:51 AM
R&D
Manufacturing

MaaT Phar­ma and CD­MO Skyephar­ma un­veil be­spoke, and po­ten­tial­ly largest, mi­cro­bio­me fa­cil­i­ty in Eu­rope

Anna Brown

News Reporter

MaaT Phar­ma and CD­MO Skyephar­ma have just com­plet­ed build­ing what might be the largest cGMP mi­cro­bio­me fa­cil­i­ty in Eu­rope. Com­plet­ed in 12 months, the 17 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Ky­owa Kirin ac­quires ex-US rights to Ku­ra’s leukemia treat­ment for $330M up­front

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times